Intended for healthcare professionals

News Extra [these Stories Appear Only On The Web]

Drug company chairman calls for trial period to evaluate drugs

BMJ 1999; 319 doi: (Published 04 December 1999) Cite this as: BMJ 1999;319:1456
  1. Roger Dobson
  1. Abergavenny

    Demands that the pharmaceutical industry should show “value in use” at the time of a drug's launch are misguided, GlaxoWellcome's chairman, Sir Richard Sykes, warned this week. He suggested that a new way forward would be a system where drugs could be value tested while they were on the market for a …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription